A novel and simple method to produce large amounts of recombinant soluble peptide/major histocompatibility complex monomers for analysis of antigen-specific human T cell receptors.


Journal

New biotechnology
ISSN: 1876-4347
Titre abrégé: N Biotechnol
Pays: Netherlands
ID NLM: 101465345

Informations de publication

Date de publication:
25 Mar 2019
Historique:
received: 14 07 2018
revised: 14 11 2018
accepted: 18 11 2018
pubmed: 23 11 2018
medline: 15 1 2019
entrez: 23 11 2018
Statut: ppublish

Résumé

Soluble peptide/major histocompatibility complex (p/MHC) tetramers that directly bind to T cell receptors (TCRs) allow the direct quantification, phenotypic characterization and isolation of antigen-specific T cells. Conventionally, soluble p/MHC tetramers have been produced using Escherichia coli, but this method requires refolding of the recombinant proteins. Here, a novel and technically simple method that does not require protein refolding in vitro has been developed for the high-throughput generation of soluble and functional p/MHC-single chain trimer (SCT) monomers and tetramers in a mammalian cell system. The p/MHC-SCT tetramers generated by this method bound to the corresponding antigen-specific TCRs. Moreover, the immobilized p/MHC-SCT monomers effectively activated antigen-specific T cell lines as well as primary T cells in an antigen-specific manner. This technique provides a robust improvement in the technology, such that recombinant soluble p/MHC monomers and tetramers can be produced more readily and which enables their use in analysis of antigen-specific T cells in basic and clinical studies.

Identifiants

pubmed: 30465909
pii: S1871-6784(18)31675-3
doi: 10.1016/j.nbt.2018.11.005
pii:
doi:

Substances chimiques

Antigens 0
Peptides 0
Receptors, Antigen, T-Cell 0
Recombinant Proteins 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

169-177

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Fulian Lyu (F)

Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences (Medicine), University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Tatsuhiko Ozawa (T)

Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences (Medicine), University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan. Electronic address: toz@med.u-toyama.ac.jp.

Hiroshi Hamana (H)

Department of Innovative Cancer Immunotherapy, Graduate School of Medicine and Pharmaceutical Sciences (Medicine), University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Eiji Kobayashi (E)

Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences (Medicine), University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Atsushi Muraguchi (A)

Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences (Medicine), University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Hiroyuki Kishi (H)

Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences (Medicine), University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH